Katherine Koot
Primary Podiatric Medicine · Milford, MANPI 1790120913
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Integra Lifesciences Corporation at 57.2% of the total.
Across 24 payments — averaging $55.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$759
- Mimedx Group, Inc.$222
- Paratek Pharmaceuticals, Inc.$109
- Smith+Nephew$100
- Orthofix Medical, Inc.$74
- Zimmer Biomet$47
- plus $15 from 1 others
What the payments were for
- Food & beverage$65449%
- Other$67151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 5 | $759 |
| Mimedx Group, Inc. | 4 | $222 |
| Paratek Pharmaceuticals, Inc. | 6 | $109 |
| Smith+Nephew | 4 | $100 |
| Orthofix Medical, Inc. | 2 | $74 |
| Zimmer Biomet | 2 | $47 |
| Averitas Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACell$671
How this compares
Too few primary podiatric medicine providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 69 | $2,495 |
| CiclopiroxCiclopirox Olamine | 22 | $652 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $522 |
| Ammonium Lactate | 18 | $280 |
| Mupirocin | 32 | $278 |
| Diclofenac Sodium | 12 | $158 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $142 |
| Cephalexin | 17 | $129 |
| Meloxicam | 28 | $122 |
| Methylprednisolone | 17 | $102 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Milford
- Anthony TicknerHudson$284K
- David AlperBelmont$4K
- Jeffrey ResnickHarvard$2K
- Richard GenoveseGardner$1K
- Robert UhrichBoston$1K
- Dominick GaribaldiWinthrop$681
- Edward MostoneMedford$606
- Paul HeffernanCambridge$321
- Frank MoleWilbraham$229
- Jack DalyMalden$169
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.